BSE Live
Dec 26, 16:01Prev. Close
398.05
Open Price
395.55
Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
0.00 (0)
NSE Live
Dec 26, 15:59Prev. Close
398.35
Open Price
398.30
Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
395.45 (211)
| Key Financial Ratios of Biocon (in Rs. Cr.) | Mar 05 | Mar 04 | |
| Per Share Ratios | |||
| Basic EPS (Rs.) | 19.75 | 13.86 | |
| Diluted EPS (Rs.) | 19.75 | 13.86 | |
| Cash EPS (Rs.) | 21.88 | 15.49 | |
| Book Value [ExclRevalReserve]/Share (Rs.) | 74.00 | 56.29 | |
| Book Value [InclRevalReserve]/Share (Rs.) | 74.14 | 56.29 | |
| Revenue from Operations/Share (Rs.) | 71.26 | 50.19 | |
| PBDIT/Share (Rs.) | 23.80 | 17.96 | |
| PBIT/Share (Rs.) | 21.56 | 16.33 | |
| PBT/Share (Rs.) | 21.38 | 16.17 | |
| Net Profit/Share (Rs.) | 19.65 | 13.86 | |
| NP After MI And SOA / Share (Rs.) | 19.75 | 13.86 | |
| Profitability Ratios | |||
| PBDIT Margin (%) | 33.39 | 35.77 | |
| PBIT Margin (%) | 30.26 | 32.53 | |
| PBT Margin (%) | 30.00 | 32.21 | |
| Net Profit Margin (%) | 27.57 | 27.62 | |
| NP After MI And SOA Margin (%) | 27.72 | 27.62 | |
| Return on Networth/Equity (%) | 26.72 | 24.62 | |
| Return on Capital Employed (%) | 24.88 | 21.48 | |
| Return on Assets (%) | 18.08 | 17.63 | |
| Total Debt/Equity (X) | 0.07 | 0.11 | |
| Asset Turnover Ratio (%) | 65.25 | 63.83 | |
| Liquidity Ratios | |||
| Current Ratio (X) | 0.93 | 3.87 | |
| Quick Ratio (X) | 0.68 | 3.26 | |
| Inventory Turnover Ratio (X) | 9.66 | 5.86 | |
| Dividend Payout Ratio (NP) (%) | 10.12 | 7.21 | |
| Dividend Payout Ratio (CP) (%) | 9.09 | 6.45 | |
| Earnings Retention Ratio (%) | 89.88 | 92.79 | |
| Cash Earnings Retention Ratio (%) | 90.91 | 93.55 | |
| Coverage Ratios | |||
| Interest Coverage Ratios (%) | 116.16 | 101.47 | |
| Interest Coverage Ratios (Post Tax) (%) | 116.16 | 101.47 | |
| Valuation Ratios | |||
| Enterprise Value (Cr.) | 4,128.78 | 0.00 | |
| EV/Net Operating Revenue (X) | 5.79 | 0.00 | |
| EV/EBITDA (X) | 17.35 | 0.00 | |
| MarketCap/Net Operating Revenue (X) | 5.73 | 0.00 | |
| Retention Ratios (%) | 89.87 | 92.78 | |
| Price/BV (X) | 5.52 | 0.00 | |
| Price/Net Operating Revenue | 5.73 | 0.00 | |
| Earnings Yield | 0.05 | 0.00 |
19.12.2025
09.12.2025
08.12.2025
20.11.2025
Biocon falls 5% after Citi double downgrades stock to 'Sell'; Check latest target price